<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03370848</url>
  </required_header>
  <id_info>
    <org_study_id>039</org_study_id>
    <nct_id>NCT03370848</nct_id>
  </id_info>
  <brief_title>Effects of Psyllium on Niacin Tolerability</brief_title>
  <official_title>A Prospective Randomized, Open-Label, Crossover Study on the Effects of Psyllium on Niacin Tolerability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Greater Los Angeles Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Greater Los Angeles Healthcare System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether psyllium is effective in reducing flushing
      due to niacin and also to measure the effect of niacin on cholesterol levels.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Global Flushing Severity Score</measure>
    <time_frame>up to 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HDL</measure>
    <time_frame>Baseline, &amp; end of week 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL</measure>
    <time_frame>Baseline, &amp; end of week 6</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Flushing</condition>
  <condition>Hyperlipidemias</condition>
  <condition>Dyslipidemias</condition>
  <arm_group>
    <arm_group_label>Psyllium plus Aspirin and Niacin ER</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Niacin ER 500mg tablet - take 1 niacin ER 500mg tablet at least two hours before bedtime for two weeks, then increase niacin ER to two 500mg tablets (1,000 mg total) for two weeks, then increase to three niacin ER 500mg tablets (1,500 mg total) for two weeks.
Aspirin 325mg tablet - take 1 aspirin 325 mg tablet 30 minutes prior to niacin ER
Psyllium 1.7gm wafers - take 2 wafers (3.4 grams total) along with aspirin 30 minutes prior to niacin ER</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspirin and Niacin ER</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Niacin ER 500mg tablet - take 1 niacin ER 500mg tablet at least two hours before bedtime for two weeks, then increase niacin ER to two 500mg tablets (1,000 mg total) for two weeks, then increase to three niacin ER 500mg tablets (1,500 mg total) for two weeks.
Aspirin 325mg tablet - take 1 aspirin 325 mg tablet 30 minutes prior to niacin ER</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Psyllium</intervention_name>
    <description>Aspirin 325 mg tablet and two 1.7gm psyllium wafers (3.4gm total) 30 minutes prior to niacin ER</description>
    <arm_group_label>Psyllium plus Aspirin and Niacin ER</arm_group_label>
    <other_name>Metamucil</other_name>
    <other_name>Cilium</other_name>
    <other_name>Fiberall</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
    <description>Aspirin 325 mg tablet 30 minutes prior to niacin ER</description>
    <arm_group_label>Psyllium plus Aspirin and Niacin ER</arm_group_label>
    <arm_group_label>Aspirin and Niacin ER</arm_group_label>
    <other_name>Bayer</other_name>
    <other_name>Ecotrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are starting ER niacin for clinical indication by a healthcare provider

          -  No prior use of psyllium for the past 2 months

          -  No prior use of niacin for the past 3 months

          -  Ability to give informed consent

          -  Must be reachable by telephone

        Exclusion Criteria:

          -  Known contraindications to ER niacin, aspirin or psyllium (including: presence of
             nausea, vomiting, abdominal pain, intestinal obstruction, or fecal impaction; known
             hypersensitivity to ER niacin, aspirin or psyllium; severe hepatic dysfunction,
             transaminitis; history of gastrointestinal bleed attributable to aspirin induced
             gastritis)

          -  Patient who are unable to perform assessment of flushing using the standardized scales
             or questionnaires

          -  Patients who are pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Freny V Mody, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Greater Los Angeles Healthcare System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA West Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2016</study_first_submitted>
  <study_first_submitted_qc>December 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2017</study_first_posted>
  <last_update_submitted>December 7, 2017</last_update_submitted>
  <last_update_submitted_qc>December 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Niacin</keyword>
  <keyword>Psyllium</keyword>
  <keyword>Dietary fiber</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
    <mesh_term>Flushing</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Niacin</mesh_term>
    <mesh_term>Niacinamide</mesh_term>
    <mesh_term>Nicotinic Acids</mesh_term>
    <mesh_term>Psyllium</mesh_term>
    <mesh_term>Calcium polycarbophil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

